Senores Pharmaceuticals Announces Capacity Expansions Across Subsidiaries
Senores Pharmaceuticals Ltd 路 Others (Uncategorized) 路 29 Oct 2026, 7:31 pm
Senores Pharmaceuticals Announces Capacity Expansions Across Subsidiaries Senores Pharmaceuticals announced planned capacity expansions across its subsidiaries totaling INR 43.00 Cr, targeted for completion by end of Mar'27. Havix Group INC (USA) will expand capacity from 1.2 Bn to 2.0 Bn units for INR 18.00 Cr, while Apnar Pharma (India) will scale from 0.5 Bn to 1.2 Bn units for INR 20.00 Cr. Additionally, Ratnatris Pharmaceuticals is adding a 2.7 Mn-unit Prefilled Syringe line for INR 5.00 Cr. Funding will be sourced via internal accruals and IPO proceeds to meet growing demand.
Original exchange filing (PDF)
More announcements from Senores Pharmaceuticals Ltd
- We are pleased to announce that the manufacturing facility of our Subsidiary Company., Ratnatris Pharmaceuticals Private Limited has been awarded with the prestigious PIC/S GMP certification .... 路 18 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding transcript of earnings conference call held on October 29, 2026 路 05 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding audio recording of earnings conference call for quarter ended September 30, 2026 路 30 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible .... 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended on September 30, 2026 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Monitoring Agency report for the quarter ended September 30, 2026 路 29 Oct 2026
- We enclose herewith the Investor Presentation for Q2 & H1FY27 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Appointment of joint Statutory Auditor of the Company 路 29 Oct 2026
